J0712 HCPCS Level II code: Injection, ceftaroline fosamil, 10 mg
J0712 is the HCPCS code for “Injection, ceftaroline fosamil, 10 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0712Injection, ceftaroline fosamil, 10 mg
Short description: Ceftaroline fosamil inj
HCPCS · United States
Medicare details
The indicators CMS publishes with J0712 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2012
Where J0712 sits
- 1J codesDrugs administered other than orally
- 2Active code J0712Injection, ceftaroline fosamil, 10 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0712 mean?
J0712 is the HCPCS code for “Injection, ceftaroline fosamil, 10 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0712?
CMS lists J0712’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0712
All J codesJ0699Injection, cefiderocol, 10 mgJ0701Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mgJ0702Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mgJ0703Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mgJ0706Injection, caffeine citrate, 5 mgJ0710Injection, cephapirin sodium, up to 1 gmJ0713Injection, ceftazidime, per 500 mgJ0714Injection, ceftazidime and avibactam, 0.5 g/0.125 gJ0715Injection, ceftizoxime sodium, per 500 mgJ0716Injection, centruroides immune f(ab)2, up to 120 milligramsJ0717Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)J0720Injection, chloramphenicol sodium succinate, up to 1 gm